JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Here we describe a protocol for generating human induced-pluripotent stem cells from patient-derived fibroblast-like synoviocytes, using a lentiviral system without feeder cells.

Streszczenie

Mature somatic cells can be reversed into a pluripotent stem cell-like state using a defined set of reprogramming factors. Numerous studies have generated induced-Pluripotent Stem Cells (iPSCs) from various somatic cell types by transducing four Yamanaka transcription factors: Oct4, Sox2, Klf4 and c-Myc. The study of iPSCs remains at the cutting edge of biological and clinical research. In particular, patient-specific iPSCs can be used as a pioneering tool for the study of disease pathobiology, since iPSCs can be induced from the tissue of any individual. Rheumatoid arthritis (RA) is a chronic inflammatory disease, classified by the destruction of cartilage and bone structure in the joint. Synovial hyperplasia is one of the major reasons or symptoms that lead to these results in RA. Fibroblast-like Synoviocytes (FLSs) are the main component cells in the hyperplastic synovium. FLSs in the joint limitlessly proliferate, eventually invading the adjacent cartilage and bone. Currently, the hyperplastic synovium can be removed only by a surgical procedure. The removed synovium is used for RA research as a material that reflects the inflammatory condition of the joint. As a major player in the pathogenesis of RA, FLSs can be used as a material to generate and investigate the iPSCs of RA patients. In this study, we used the FLSs of a RA patient to generate iPSCs. Using a lentiviral system, we discovered that FLSs can generate RA patient-specific iPSC. The iPSCs generated from FLSs can be further used as a tool to study the pathophysiology of RA in the future.

Wprowadzenie

Pluripotent stem cells are the next-generation platform in various clinical and biological fields. They are a promising tool that can be used in disease modeling, drug screening, and regenerative medical therapy. Human Embryonic Stem Cells (hESCs) were mainly used to study and understand pluripotent cells. However, isolated by the destruction of the human blastocyst, hESCs are associated with several ethical concerns. In 2007, Dr. Shinya Yamanaka and his team reversed the cell programming process and developed stem cells from human adult somatic cells1,2. Therefore, unlike hESCs, induced-Pluripotent Stem Cells (iPSCs) can be generated from mature somatic ce....

Access restricted. Please log in or start a trial to view this content.

Protokół

Ethics Statement: This study protocol was approved by the institutional review board of The Catholic University of Korea (KC12TISI0861).

1. Synoviocyte Isolation and Expansion

  1. Synoviocyte Isolation
    1. Sterilize two pairs of surgical scissors and one pair of forceps.
    2. Transfer the synovial tissue to a 100 mm dish and wash with 5 ml of phosphate-buffered saline (PBS) containing 1% penicillin/streptomycin.
    3. Cut off the yellowish fat tissue and bone residues. Transfer the trimmed tissue to a well of a 6-well plate and add 5 ml of Dulbecco's modified Eagle's medium (DMEM) with 20% Fetal bovine serum (FBS).
    4. ....

Access restricted. Please log in or start a trial to view this content.

Wyniki

In this study, we describe a protocol to generate iPSCs from FLSs using a lentiviral system. Figure 1A shows a simple scheme of the FLS isolation protocol. Following surgical removal of the synovium, the tissue was chopped into small pieces using surgical scissors. Collagenase was added to isolate the cells from the clumps of tissue. Cells were incubated for 14 days before further processing. Figure1B shows the morphology of the isolated .......

Access restricted. Please log in or start a trial to view this content.

Dyskusje

Before the discovery of iPSCs, scientists mainly used ESCs to study stem cell biology and other cell lineages through differentiation. However, ESCs originate from the inner mass of a blastocyst, which is an early-stage embryo. To isolate ESCs, destruction of the blastocyst is inevitable, raising ethical issues that are impossible to overcome. Moreover, although ESCs have stemness characteristics and pluripotency, they cannot be obtained from individuals and are sometimes not an ideal tool for personalized analysis and d.......

Access restricted. Please log in or start a trial to view this content.

Ujawnienia

The authors have nothing to disclose.

Podziękowania

This work was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (HI13D2188).

....

Access restricted. Please log in or start a trial to view this content.

Materiały

NameCompanyCatalog NumberComments
100 mm DishTPP93100
6-well PlateTPP92006
50 ml Cornical TubeSPL50050
15 mlL Cornical TubeSPL50015
10 ml Disposable PipetteFalcon7551
5 ml Disposable PipetteFalcon7543
12-well PlateTPP92012
FLS Isolation Materials
Surgical Scissors
Surgical Forcep
DPBSLife Technologies14190-144
DMEMLife Technologies11995-073
Penicilin StreptomycinSigma AldrichP4333
Fetal Bovine Serum (FBS)Life Technologies16000-044
CollagenaseSigma AldrichC6885-100MG
ParafilmSigma Aldrich54956
PBS/1 mM EDTALife Technologies12604-039
iPSC Generation Materials
DMEMLife Technologies11885
MEM Non-Essential Amino Acids Solution (100x)Life Technologies11140-050
β-MercaptoethanolSigma AldrichM3148
PolybreneChemiconTR-1003-G
Penicilin StreptomycinLife TechnologiesP4333
Fetal Bovine Serum (FBS)Life Technologies16000-044
DPBSLife Technologies14190-144
Lentivirus
DMEM/F12, HEPESLife Technologies11330-057iPSC media ingredient (500 ml)
Sodium BicarbonateLife Technologies25080-094iPSC media ingredient (Conc.: 543 μg/ml)
Sodium SeleniteSigma AldrichS5261iPSC media ingredient  (Conc.: 14 ng/mL)
Human TransfferinSigma AldrichT3705iPSC media ingredient (Conc.: 10.7 μg/ml)
Basic FGF2Peprotech100-18BiPSC media ingredient  (Conc.: 100 ng/ml)
Human InsulinLife Technologies12585-014iPSC media ingredient (Conc.: 20 μg/ml)
Human TGFβ1Peprotech100-21iPSC media ingredient (Conc.: 2 ng/ml)
Ascorbic AcidSigma AldrichA8960iPSC media ingredient  (Conc.: 64 μg/ml)
PolybreneChemiconTR-1003
Sodium ButyrateSigma AldrichB5887
VitronectinLife TechnologiesA14700
ROCK InhibitorSigma AldrichY0503
Guality Control Materials
18 mm Cover GlassSuperiorHSU-0111580
4% Paraformaldyhyde (PFA)Tech & InnovationBPP-9004
Triton X-100BIOSESANG9002-93-1
Bovine Serum Albumin (BSA)Vector LabSP-5050
Anti-SSEA4 AntibodyMilliporeMAB4304
Anti-Oct4 AntibodySanta CruzSC9081
Anti-TRA-1-60 AntibodyMilliporeMAB4360
Anti-Sox2 AntibodyBiolegend630801
Anti-TRA-1-81 AntibodyMilliporeMAB4381
Anti-Klf4 AntibodyAbcamab151733
Alexa Fluor 488 goat anti-mouse IgG (H+L) antibodyMolecular ProbeA11029
Alexa Fluor 594 goat anti-rabbit IgG (H+L) antibodyMolecular ProbeA11037
DAPIMolecular ProbeD1306
Prolong gold antifade reagentInvitrogenP36934
Slide Glass, CoatedHyun Il Lab-MateHMA-S9914
TrizolInvitrogen15596-018
ChloroformSigma Aldrich366919
IsoprypylalcoholMillipore109634
EthanolDuksan64-17-5
RevertAid First Strand cDNA Synthesis kitThermo ScientficK1622
i-Taq DNA PolymeraseiNtRON BIOTECH25021
UltraPure 10x TBE BufferLife Technologies15581-044
loading starDyne BioA750
AgaroseSigma-Aldrich9012-36-6
1 kb (+) DNA ladder markerEnzynomicsDM003
Alkaline PhosphataseMilliporeSCR004

Odniesienia

Access restricted. Please log in or start a trial to view this content.

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Induced pluripotent Stem CellsIPSCsFibroblast like SynoviocytesRheumatoid ArthritisSynovial TissueSynoviocyte CultureCollagenaseDMEMFBSCell ExpansionCell DissociationEDTA

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone